Annual Accounts Payable
$2.68 M
+$540.00 K+25.28%
December 1, 2024
Summary
- As of February 21, 2025, KRBP annual accounts payable is $2.68 million, with the most recent change of +$540.00 thousand (+25.28%) on December 1, 2024.
- During the last 3 years, KRBP annual accounts payable has risen by +$461.70 thousand (+20.85%).
- KRBP annual accounts payable is now -63.38% below its all-time high of $7.31 million, reached on December 31, 2022.
Performance
KRBP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.68 M
+$983.00 K+58.06%
December 1, 2024
Summary
- As of February 21, 2025, KRBP quarterly accounts payable is $2.68 million, with the most recent change of +$983.00 thousand (+58.06%) on December 1, 2024.
- Over the past year, KRBP quarterly accounts payable has increased by +$983.00 thousand (+58.06%).
- KRBP quarterly accounts payable is now -67.17% below its all-time high of $8.15 million, reached on March 31, 2023.
Performance
KRBP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KRBP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.3% | +58.1% |
| 3 y3 years | +20.9% | -59.6% |
| 5 y5 years | +491.5% | -59.6% |
KRBP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.4% | +25.3% | -67.2% | +58.1% |
| 5 y | 5-year | -63.4% | +491.5% | -67.2% | +491.5% |
| alltime | all time | -63.4% | +1121.4% | -67.2% | +491.5% |
Kiromic BioPharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.68 M(+25.3%) | $2.68 M(+58.1%) |
| Sep 2024 | - | $1.69 M(-15.2%) |
| Jun 2024 | - | $2.00 M(-0.2%) |
| Mar 2024 | - | $2.00 M(-6.4%) |
| Dec 2023 | $2.14 M(-70.8%) | $2.14 M(-49.7%) |
| Sep 2023 | - | $4.25 M(-35.9%) |
| Jun 2023 | - | $6.62 M(-18.8%) |
| Mar 2023 | - | $8.15 M(+11.5%) |
| Dec 2022 | $7.31 M | $7.31 M(+12.5%) |
| Sep 2022 | - | $6.49 M(+56.0%) |
| Jun 2022 | - | $4.16 M(+80.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.30 M(+4.0%) |
| Dec 2021 | $2.21 M(+232.9%) | $2.21 M(+138.7%) |
| Sep 2021 | - | $927.70 K(-17.5%) |
| Jun 2021 | - | $1.12 M(-6.6%) |
| Mar 2021 | - | $1.20 M(+80.9%) |
| Dec 2020 | $665.20 K(+47.0%) | $665.20 K(-60.2%) |
| Sep 2020 | - | $1.67 M(+32.6%) |
| Jun 2020 | - | $1.26 M(+94.7%) |
| Mar 2020 | - | $647.90 K(+43.2%) |
| Dec 2019 | $452.40 K(+106.5%) | $452.40 K |
| Dec 2018 | $219.10 K | - |
FAQ
- What is Kiromic BioPharma annual accounts payable?
- What is the all time high annual accounts payable for Kiromic BioPharma?
- What is Kiromic BioPharma annual accounts payable year-on-year change?
- What is Kiromic BioPharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly accounts payable year-on-year change?
What is Kiromic BioPharma annual accounts payable?
The current annual accounts payable of KRBP is $2.68 M
What is the all time high annual accounts payable for Kiromic BioPharma?
Kiromic BioPharma all-time high annual accounts payable is $7.31 M
What is Kiromic BioPharma annual accounts payable year-on-year change?
Over the past year, KRBP annual accounts payable has changed by +$540.00 K (+25.28%)
What is Kiromic BioPharma quarterly accounts payable?
The current quarterly accounts payable of KRBP is $2.68 M
What is the all time high quarterly accounts payable for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly accounts payable is $8.15 M
What is Kiromic BioPharma quarterly accounts payable year-on-year change?
Over the past year, KRBP quarterly accounts payable has changed by +$983.00 K (+58.06%)